07 Jul, 2014Why Do Powerful Cancer Drugs Fail?


It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work — for…

Read More

01 Oct, 2013Patient-Reported Outcomes In Cancer Management – Part 2


A personalized medicine approach to clinical cancer therapy does not necessarily translate into a patient-centered approach as discussed in part 1 of this…

Read More

26 Sep, 2013Patient-Centered Outcomes in the Clinic – Part 1


In different regulatory and research settings, it is now being realized that the need to consider patient-centered outcomes is paramount. We invited Dr Sandeep…

Read More

19 Aug, 2013Drug Discovery News – Kevin Lustig talks about Outsourcing Oncology


This month Drug Discovery News published Dr Kevin Lustig’s editorial discussing how outsourcing is a viable strategy for advancing oncology research. Oncology outsourcing is…

Read More

25 Jul, 2013Studying the RAS Gene for Oncology Treatment


An oncogene is a gene that can potentially cause cancer. RAS is a common class of oncogene and the focus of researchers worldwide,…

Read More

11 Jul, 2013In Vitro Oncology versus In Vivo Models


As previously discussed, there is great value in using in vivo models such as genetically modified mice and xenograft models for oncology research. However…

Read More

27 Jun, 2013Xenograft Advances in Oncology


Xenograft is animal tissue implanted into a different species and is often used for evaluating treatment for disease and organ failure. Currently, xenograft mice…

Read More

20 Jun, 2013Oncology Research Using Genetically Engineered Mouse Models


Oncology research using genetically engineered mice (GEM) to express oncogenes and model cancers has grown exponentially in the past 30 years[1]. Although there are key differences…

Read More